Cookies

Like most websites The Medicine Maker uses cookies. In order to deliver a personalized, responsive service and to improve the site, we remember and store information about how you use it. Learn more.
Subscribe to Newsletter

Clinical Trials

Discovery & Development Drug Discovery

Checkmate for Cachexia?

| Angus Stewart

An interview with Ken Gruber of Endevica Bio on his work producing a treatment for cachexia, a wasting condition common in late-stage cancer.

Business & Regulation Standards & Regulation

The Sacred Texts

| Sue Batchelor

New ICH guideline revisions are imminent. Sue Batchelor of Cmed shares her thoughts on how sponsors and CROs can prepare themselves.

Manufacture Bioprocessing - Upstream & Downstream

A New Focus for Cancer Therapeutics

| Joe Sinclair

Joe Sinclair gives his view on how to be successful with oncolytic virotherapy.

Discovery & Development Drug Discovery

ADCs: Still Room for Improvement!

| Antoine Attinger

Antibody drug conjugates are starting to transform cancer treatments, so let’s maintain the momentum.

Business & Regulation Clinical Trials

Paranoid or Prepared?

| Angus Stewart

Stating an intention to be ready to win in any biowarzone, the US military has commissioned Dynavax to develop a vaccine for the plague.

Discovery & Development Clinical Trials

Please, Sir, May I Have Some Samples?

| Robert Hewitt

Biotech companies need good patient samples, but hospitals are not always obliging...

Discovery & Development Clinical Trials

Taking the Trial to the Patient

| Stephanie Sutton

The way the pharma industry has traditionally handled clinical trials does not make participation easy.

Business & Regulation Clinical Trials

Remembering Henrietta

| Maryam Mahdi

On the 70th anniversary of death Henrietta Lacks, we examine her contributions to science and what they mean for modern research.

Business & Regulation Standards & Regulation

Of Medicine and Machine Learning

| Angus Stewart, Stephanie Sutton

AI is expanding into medicine. Are the world’s regulators ready?

Discovery & Development Clinical Trials

Updates Ready: Reboot Necessary

| Temitope Keyes

Aging digital systems limit the potential of decentralized trials. It's time to rethink the technologies driving them.

Register to The Medicine Maker

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:
  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Medicine Maker magazine

Register